22 U.S.C. § 7635 — Report on treatment activities by relevant executive branch agencies
submitted 23 years ago by Pub. L. 108-25 to r/title-22-FOREIGN-RELATIONS-AND-INTERCOURSE · 250 words · no verdicts yet
This section requires a report about executive-branch treatment activities for people in foreign countries who have HIV or AIDS. It specifies the treatment, pilot-project, and prevention information the report must contain.
(a) In general No later than 15 months after May 27, 2003 , the President must submit to appropriate congressional committees* a report on the programs and activities of the relevant executive branch agencies* that are directed to the treatment of individuals in foreign countries infected with HIV* or living with AIDS*.
(b) Report elements The report must include—
(1) a description of the activities of relevant executive branch agencies with respect to—
(A) the treatment of opportunistic infections;
(B) the use of antiretrovirals;
(C) the status of research into successful treatment protocols for individuals in the developing world;
(D) technical assistance and training of local health care workers (in countries affected by the pandemic) to administer antiretrovirals, manage side effects, and monitor patients’ viral loads and immune status;
(E) the status of strategies to promote sustainability of HIV/AIDS* pharmaceuticals (including antiretrovirals) and the effects of drug resistance on HIV/AIDS patients; and
(F) the status of appropriate law enforcement officials working to ensure that HIV/AIDS pharmaceutical treatment is not diminished through illegal counterfeiting and black market sales of that pharmaceuticals;
(2) information on existing pilot projects, including a discussion of why a given population was selected, the number of people treated, the cost of treatment, the mechanisms established to ensure that treatment is being administered effectively and safely, and plans for scaling up pilot projects (including projected timelines and required resources); and
(3) an explanation of how those activities relate to efforts to prevent the transmission of the HIV infection.
Not later than 15 months after May 27, 2003, the President shall submit to appropriate congressional committees* a report on the programs and activities of the relevant executive branch agencies* that are directed to the treatment of individuals in foreign countries infected with HIV* or living with AIDS*.
The report shall include—
a description of the activities of relevant executive branch agencies with respect to—
the treatment of opportunistic infections;
the use of antiretrovirals;
the status of research into successful treatment protocols for individuals in the developing world;
technical assistance and training of local health care workers (in countries affected by the pandemic) to administer antiretrovirals, manage side effects, and monitor patients’ viral loads and immune status;
the status of strategies to promote sustainability of HIV/AIDS* pharmaceuticals (including antiretrovirals) and the effects of drug resistance on HIV/AIDS patients; and
the status of appropriate law enforcement officials working to ensure that HIV/AIDS pharmaceutical treatment is not diminished through illegal counterfeiting and black market sales of such pharmaceuticals;
information on existing pilot projects, including a discussion of why a given population was selected, the number of people treated, the cost of treatment, the mechanisms established to ensure that treatment is being administered effectively and safely, and plans for scaling up pilot projects (including projected timelines and required resources); and
an explanation of how those activities relate to efforts to prevent the transmission of the HIV infection.
Source credit: (Pub. L. 108–25, title III, § 305, May 27, 2003, 117 Stat. 739.)
- 2003Enacted · Pub. L. 108-25 · 117 Stat. 739
A history note hasn’t been published yet. The record shows enactment by Pub. L. 108-25 on 2003-05-27.
all 0 arguments · sorted by: best
no arguments yet — make the first case